Sandford D. Smith, Director at Aegerion Pharmaceuticals, Inc. (AEGR), sold 2,502 shares at $95.00 ($238K) on 2013-10-29, disclosed to the SEC on 2013-10-31.
Scheduled sale ($238k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2021-11-19 | $1.4M | — | Filing → |
| CYTK | SELL | 2021-07-21 | $403K | — | Filing → |
| CYTK | SELL | 2021-04-27 | $401K | — | Filing → |